Prevalence of HBsAg mutants and impact of hepatitis B infant immunisation in four Pacific Island countries
Abstract
The prevalence rate of hepatitis B virus (HBV) infection in Pacific Island countries is amongst the highest in the world. Hepatitis B immunisation has been incorporated into national programmes at various times, often with erratic supply and coverage, until a regionally co-ordinated programme, which commenced in 1995 ensured adequate supply. The effectiveness of these programmes was recently evaluated in four countries, Vanuatu and Fiji in Melanesia, Tonga in Polynesia and Kiribati in Micronesia. That evaluation established that the programmes had a substantial beneficial impact in preventing chronic hepatitis B infection [Vaccine 18 (2000) 3059]. Several studies of hepatitis B vaccination programmes in endemic countries have identified the potential significance of surface gene mutants as a cause for failure of immunisation. In the study outlined in this paper, we screened infected children and their mothers for the emergence and prevalence of these variants in specimens collected from the four country evaluation. Although the opportunity for the emergence of HBV vaccine escape mutants in these populations was high due to the presence of a considerable amount of the virus in the population and the selection pressure from vaccine use, there were no "a" determinant vaccine escape mutants found. This suggests that vaccine escape variants are not an important cause for failure to prevent HBV transmission in this setting. Other HBsAg variants were detected, but their functional significance remains to be determined. The failure to provide satisfactory protection during such immunisation programmes reflects the need for achieving and sustaining high vaccine coverage, improving the timeliness of doses as well as improving 'cold-chain' support, rather than the selection of vaccine-escape mutants of HBV.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The reduction in hepatitis B prevalence may have contributed to declining cirrhosis mortality in China.
“This may in part be related to a reduction in hepatitis B prevalence from 9.8% in 1992 to 7.2% in 2006 [57,58].”
From Liver cirrhosis mortality in 187 countries between 1980 and 2010: a systematic analysis (2014) · cites this paper as [58]
Hepatitis B prevalence in China decreased from 9.8% in 1992 to 7.2% in 2006.
“This may in part be related to a reduction in hepatitis B prevalence from 9.8% in 1992 to 7.2% in 2006 [57,58].”
From Liver cirrhosis mortality in 187 countries between 1980 and 2010: a systematic analysis (2014) · cites this paper as [58]
Cites
Lee, W. M. (1997) · New England Journal of Medicine · doi:10.1056/nejm199712113372406 · Cited by 2,559 · see citing works
Viral Hepatitis and Liver Disease
Vyas, G. N., Dienstag, J. L., & Hoofnagle, J. H. (1985) · Medical Entomology and Zoology · Cited by 1,867 · see citing works
Vaccine-induced escape mutant of hepatitis B virus
Carman, W. F., Karayiannis, P., Waters, J. A., Thomas, H. C., Zanetti, Â. R., Manzillo, G., & Zuckerman, A. J. (1990) · The Lancet · doi:10.1016/0140-6736(90)91874-a · Cited by 1,070 · see citing works
Self-citationVertical Transmission of Hepatitis B Antigen in Taiwan
Stevens, C. E., Beasley, R. P., Tsui, J., & Lee, W. M. (1975) · New England Journal of Medicine · doi:10.1056/nejm197504102921503 · Cited by 1,026 · see citing works
McMahon, B. J., Alward, W. L. M., Hall, D. B., Heyward, W. L., Bender, T. R., Francis, D. P., & Maynard, J. E. (1985) · The Journal of Infectious Diseases · doi:10.1093/infdis/151.4.599 · Cited by 832 · see citing works
Is a function of the secreted hepatitis B e antigen to induce immunologic tolerance in utero?
Milich, D. R., Jones, J. E., Hughes, J. L., Price, J. A., Raney, A. K., & McLachlan, A. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.17.6599 · Cited by 580 · see citing works
Genetic Prediction of Nonresponse to Hepatitis B Vaccine
Alper, C. A., Kruskall, M. S., Marcus-Bagley, D., Craven, D. E., Katz, A. J., Brink, S. J., Dienstag, J. L., Awdeh, Z., & Yunis, E. J. (1989) · New England Journal of Medicine · doi:10.1056/nejm198909143211103 · Cited by 400 · see citing works
Hepatitis B epidemiology in Asia, the Middle East and Africa
André, F. E. (2000) · Vaccine · doi:10.1016/s0264-410x(99)00456-9 · Cited by 355 · see citing works
Seroepidemiology of hepatitis B virus infection in children: Ten years of mass vaccination in Taiwan
Chen, D. (1996) · JAMA · doi:10.1001/jama.276.11.906 · Cited by 341 · see citing works
Viruses, Immunity, and Cancer: Lessons from Hepatitis B
Chisari, F. V. (2000) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64980-2 · Cited by 314 · see citing works
Protzer, U., Naumann, U., Bartenschlager, R. F. W., Berg, T., Hopf, U., Büschenfelde, K. M. Z., Neuhaus, P., & Gerken, G. (1998) · Hepatology · doi:10.1002/hep.510270138 · Cited by 270 · see citing works
Strategies to prevent and control hepatitis B and C virus infections: a global perspective
Mast, E. E., Alter, M. J., & Margolis, H. S. (1999) · Vaccine · doi:10.1016/s0264-410x(98)00415-0 · Cited by 262 · see citing works
Hsu, H., Chang, M., Liaw, S., Ni, Y., & Chen, H. (1999) · Hepatology · doi:10.1002/hep.510300511 · Cited by 257 · see citing works
de Jong, J. C., BEYER, W. E. P., Palache, A. M., Rimmelzwaan, G. F., & Osterhaus, A. D. M. E. (2000) · Journal of Medical Virology · doi:10.1002/(sici)1096-9071(200005)61:1 · Cited by 229 · see citing works
Molecular epidemiology of hepatitis B virus vaccine variants in Singapore
Cj, O. (1995) · Vaccine · doi:10.1016/0264-410x(94)00080-7 · Cited by 210 · see citing works
Hsu, H., Chang, M., Chen, D., Lee, C., & Sung, J. (1986) · Journal of Medical Virology · doi:10.1002/jmv.1890180402 · Cited by 200 · see citing works
Okamoto, H., Yano, K., Nozaki, Y., Matsui, A., Miyazaki, H., Yamamoto, K., Tsuda, F., Machida, A., & Mishiro, S. (1992) · Pediatric Research · doi:10.1203/00006450-199209000-00002 · Cited by 183 · see citing works
McMahon, G., Ehrlich, P. H., Moustafa, Z. A., McCarthy, L. A., Dottavio, D., Tolpin, M. D., Nadler, P. I., & Östberg, L. (1992) · Hepatology · doi:10.1002/hep.1840150503 · Cited by 178 · see citing works
Michael, R. P. (1966) · BMJ · doi:10.1136/bmj.1.5496.1174 · Cited by 167 · see citing works
Carman, W. F., van Deursen, F. J., Mimms, L. T., Hardie, D. R., Coppola, R., Decker, R. H., & Sanders, R. (1997) · Hepatology · doi:10.1002/hep.510260640 · Cited by 159 · see citing works
Self-citationMaynard, J. E., Kane, M., & Hadler, S. C. (1989) · Clinical Infectious Diseases · doi:10.1093/clinids/11.supplement_3.s574 · Cited by 142 · see citing works
A novel hepatitis B virus variant in the sera of immunized children
Karthigesu, V. D., Allison, L. M. C., Fortuin, M., Mendy, M. E., Whittle, H., & Howard, C. R. (1994) · Journal of General Virology · doi:10.1099/0022-1317-75-2-443 · Cited by 128 · see citing works
Ip, H. M. H., Wong, V. W., Lelie, P. N., Kuhns, M., & Reesink, H. W. (1989) · The Lancet · doi:10.1016/s0140-6736(89)90003-2 · Cited by 126 · see citing works
Ngui, S. L., O'Connell, S., Eglin, R., Heptonstall, J., & Teo, C. G. (1997) · The Journal of Infectious Diseases · doi:10.1086/514133 · Cited by 116 · see citing works
Lee, S., Lo, K., Wu, J., Tsai, Y., Wang, J.-Y., Ting, L., & Tong, M. J. (1986) · Hepatology · doi:10.1002/hep.1840060306 · Cited by 110 · see citing works
Class II HLA Alleles and Hepatitis B Virus Persistence in African Americans
Thio, C. L., Carrington, M. N., Marti, D., O’Brien, S. J., Vlahov, D., Nelson, K. E., Astemborski, J. A., & Thomas, D. L. (1999) · The Journal of Infectious Diseases · doi:10.1086/314684 · Cited by 109 · see citing works
del Canho, R., Grosheide, P. M., Schalm, S. W., de Vries, R. R. P., & Heijtink, R. A. (1994) · Journal of Hepatology · doi:10.1016/s0168-8278(05)80494-5 · Cited by 109 · see citing works
Stroffolini, T., Mele, A., Tosti, M. E., Gallo, G., Balocchini, E., Ragni, P., Santonastasi, F., Marzolini, A., Ciccozzi, M., & Moiraghi, A. R. (2000) · Journal of Hepatology · doi:10.1016/s0168-8278(00)80132-4 · Cited by 106 · see citing works
Fortuin, M., Karthigesu, V. D., Allison, L. H., Howard, C. R., Hoare, S., Mendy, M. E., & Whittle, H. (1994) · The Journal of Infectious Diseases · doi:10.1093/infdis/169.6.1374 · Cited by 90 · see citing works
Diepolder, H. M., Jung, M., Keller, E., Schraut, W., Gerlach, J.-T., Grüner, N. H., Zachoval, R., Hoffmann, R. M., Schirren, C.-A., Scholz, S., et al. (1998) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.1998.00665.x · Cited by 84 · see citing works
Ruff, T., Gertig, D. M., Otto, B., Gust, I. D., Sutanto, A., Soewarso, T. I., Kandun, N., Marschner, I. C., & Maynard, J. E. (1995) · The Journal of Infectious Diseases · doi:10.1093/infdis/171.2.290 · Cited by 82 · see citing works
Quality of vaccination services and social demand for vaccinations in Africa and Asia.
Streefland, P. H., Chowdhury, A. M., & Ramos-Jimenez, P. (1999) · PubMed · Cited by 81 · see citing works
Oon, C. L., Ning, C. W., Koh, S., & Lim, G. K. (1999) · The Journal of Infectious Diseases · doi:10.1086/314553 · Cited by 80 · see citing works
Hepatitis B virus surface mutations associated with infection after liver transplantation
Hawkins, A. E., Gilson, R. J. C., Gilbert, N., Wreghitt, T. G., Gray, J. J., Ahlers-de-Boer, I., Tedder, R. S., & Alexander, G. (1996) · Journal of Hepatology · doi:10.1016/s0168-8278(96)80179-6 · Cited by 77 · see citing works
Lee, P., Chang, L., Chin‐Yun Lee, [. H., & Chang, M. (1997) · The Journal of Infectious Diseases · doi:10.1086/514060 · Cited by 72 · see citing works
Lee, C., Huang, L., Chang, M., Hsu, C.-Y., WU, S.-J., Sung, J., & Safary, A. (1991) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-199104000-00007 · Cited by 71 · see citing works
Wilson, N., Ruff, T., Rana, B., Leydon, J. A., & LOCARNINI, S. A. (2000) · Vaccine · doi:10.1016/s0264-410x(00)00080-3 · Cited by 54 · see citing works
Self-citationHuman leukocyte antigens influence the immune response to a pre-S/S hepatitis B vaccine
McDermott, A. B., Cohen, S. B., Zuckerman, J. N., & Madrigal, J. A. (1999) · Vaccine · doi:10.1016/s0264-410x(98)00203-5 · Cited by 47 · see citing works
Immunoselected hepatitis B virus mutant
Moriyama, K., Nakajima, E., Hohjoh, H., Asayama, R., & OKOCHI, K. (1991) · The Lancet · doi:10.1016/0140-6736(91)90793-o · Cited by 45 · see citing works
He, J.-W., Lu, Q., Zhu, Q., Duan, S.-C., & Wen, Y. (1998) · Vaccine · doi:10.1016/s0264-410x(97)00182-5 · Cited by 34 · see citing works
Perinatal transmission of hepatitis B virus: Role of maternal HBeAg and anti‐HBc IgM
Hwang, L., Roggendorf, M., Beasley, R. P., & Deinhardt, F. W. (1985) · Journal of Medical Virology · doi:10.1002/jmv.1890150307 · Cited by 32 · see citing works
Chen, W. N., Oon, C. J., & Toh, I. (2000) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2000.01958.x · Cited by 30 · see citing works
Sehgal, A., Gupta, I., Sehgal, R., & Ganguly, N. K. (1992) · PubMed · Cited by 21 · see citing works
Control of HBV and HDV infection in an isolated pacific Island: 1. pattern of infection
Speed, B. R., Dimitrakakis, M., Thoma, K., & Gust, I. D. (1989) · Journal of Medical Virology · doi:10.1002/jmv.1890290104 · Cited by 19 · see citing works
Chen, W. (2000) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(00)00750-4 · Cited by 18 · see citing works
Phillips, A. N., McLean, A. R., Johnson, M. A., Tyrer, M., Emery, V. C., Griffiths, P. D., Bofill, M., Janossy, G., & Loveday, C. (1997) · Journal of Medical Virology · doi:10.1002/(sici)1096-9071(199711)53:3 · Cited by 14 · see citing works
Has immunology become important to hepatologists?
Thomas, H. C., & Lever, A. M. L. (1986) · PubMed · Cited by 11 · see citing works
Chang, S. S., Toni, R., Gilden, R. V., Hatanaka, M., & Huebner, R. J. (1969) · Journal of General Virology · doi:10.1099/0022-1317-5-3-443 · Cited by 10 · see citing works
An efficient extraction method from blood clots for studies requiring both host and viral DNA
Basuni, Butterworth, Cooksley, Locarnini, & Carman (2000) · Journal of Viral Hepatitis · doi:10.1046/j.1365-2893.2000.00206.x · Cited by 10 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Liver cirrhosis mortality in 187 countries between 1980 and 2010: a systematic analysis
Mokdad, A. A., Lopez, A. D., Shahraz, S., Lozano, R., Mokdad, A. H., Stanaway, J., Murray, C. J., & Naghavi, M. (2014) · BMC Medicine · doi:10.1186/s12916-014-0145-y · Cited by 1,129 · see citing works
Shouval, D. (2003) · Journal of Hepatology · doi:10.1016/s0168-8278(03)00152-1 · Cited by 471 · see citing works
Hepatitis B virus genetic diversity in Latin America
Devesa, M., & Pujol, F. H. (2007) · Virus Research · doi:10.1016/j.virusres.2007.01.004 · Cited by 81 · see citing works
HBsAg variants: Diagnostic-escape and diagnostic dilemma
Alavian, S. M., Carman, W. F., & Jazayeri, S. M. (2012) · Journal of Clinical Virology · doi:10.1016/j.jcv.2012.04.027 · Cited by 80 · see citing works
Self-citationHsu, H., Chang, M., Ni, Y., Chiang, C., Chen, H., Wu, J., & Chen, P. (2010) · The Journal of Infectious Diseases · doi:10.1086/651378 · Cited by 78 · see citing works
Lai, M., Lin, T., Tsao, K., Huang, C., Hsiao, M., Liang, K., & Yeh, C. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.05.002 · Cited by 70 · see citing works
Hepatitis B and Pregnancy: Virologic and Immunologic Characteristics
Joshi, S. S., & Coffin, C. S. (2020) · Hepatology Communications · doi:10.1002/hep4.1460 · Cited by 69 · see citing works
Hepatitis B virus S gene escape mutants
Purdy, M. A. (2007) · Asian Journal of Transfusion Science · doi:10.4103/0973-6247.33445 · Cited by 64 · see citing works
Global control of hepatitis B virus: does treatment-induced antigenic change affect immunization?
Clements, C. J., Coghlan, B., Creati, M., LOCARNINI, S. A., Tedder, R. S., & Torresi, J. (2009) · Bulletin of the World Health Organization · doi:10.2471/blt.08.065722 · Cited by 62 · see citing works
Self-citationThe virological aspects of hepatitis B
Valaydon, Z. S., & LOCARNINI, S. A. (2017) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2017.04.013 · Cited by 53 · see citing works
Self-citationClinical relevance of hepatitis B virus variants
Gao, S. (2015) · World Journal of Hepatology · doi:10.4254/wjh.v7.i8.1086 · Cited by 46 · see citing works
Cross-Protection of Hepatitis B Vaccination among Different Genotypes
Inoue, T., & Tanaka, Y. (2020) · Vaccines · doi:10.3390/vaccines8030456 · Cited by 45 · see citing works
Tharmaphornpilas, P., Rasdjarmrearnsook, A., Plianpanich, S., Sa‐nguanmoo, P., & Poovorawan, Y. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.08.034 · Cited by 42 · see citing works
Hepatitis B virus and hepatitis C virus co-infection: additive players in chronic liver disease?
Raimondo, G., Cacciamo, G., & Saitta, C. (2005) · Annals of Hepatology · doi:10.1016/s1665-2681(19)32072-1 · Cited by 42 · see citing works
Current concepts on immunopathogenesis of hepatitis B virus infection
Peeridogaheh, H., Meshkat, Z., Habibzadeh, S., Arzanlou, M., Mohammadshahi, J., Rostami, S., Gerayli, S., & Teimourpour, R. (2017) · Virus Research · doi:10.1016/j.virusres.2017.12.007 · Cited by 41 · see citing works
Yan, B., Lv, J., Feng, Y., Liu, J., Ji, F., Xu, A., & Zhang, L. (2017) · Scientific Reports · doi:10.1038/s41598-017-07085-z · Cited by 37 · see citing works
Machmud, P. B., Glasauer, S., Gottschick, C., & Mikolajczyk, R. (2021) · Vaccines · doi:10.3390/vaccines9060625 · Cited by 32 · see citing works
Hepatitis B virus and hepatitis C virus infections in children
Tovo, P., Lazier, L., & Versace, A. (2005) · Current Opinion in Infectious Diseases · doi:10.1097/01.qco.0000168388.24142.2b · Cited by 31 · see citing works
Hepatitis B Virus (HBV) and S-Escape Mutants: From the Beginning until Now
María, L. (2015) · Journal of Human Virology & Retrovirology · doi:10.15406/jhvrv.2015.02.00046 · Cited by 30 · see citing works
Epidemiology of HBV S-gene mutants in the Liguria Region, Italy
Sticchi, L., Caligiuri, P., Cacciani, R., Alicino, C., & Bruzzone, B. M. (2013) · Human Vaccines & Immunotherapeutics · doi:10.4161/hv.23236 · Cited by 27 · see citing works
Molecular epidemiology of hepatitis delta virus in the Western Pacific region
Han, M., Littlejohn, M., Yuen, L. K. W., Edwards, R., Devi, U., Bowden, S., Ning, Q., Locarnini, S., & Jackson, K. (2014) · Journal of Clinical Virology · doi:10.1016/j.jcv.2014.05.021 · Cited by 26 · see citing works
Self-citationTsatsralt‐Od, B., Takahashi, M., Endo, K., Dondog, A., Buyankhuu, O., Ninomiya, M., Lorenzo, F., & Okamoto, H. (2007) · Journal of Medical Virology · doi:10.1002/jmv.20867 · Cited by 25 · see citing works
An overview of occult hepatitis B infection (OBI) with emphasis on HBV vaccination
Delghandi, S., Raoufinia, R., Shahtahmasbi, S., Meshkat, Z., Gouklani, H., & Gholoobi, A. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e37097 · Cited by 24 · see citing works
Carter, K., Tovu, V., Langati, J. T., Buttsworth, M., Dingley, L., Calo, A., Harrison, G., Rao, C., López, A. D., & Taylor, R. J. (2016) · Population Health Metrics · doi:10.1186/s12963-016-0074-4 · Cited by 23 · see citing works
Cuestas, M. L., Mathet, V. L., Ruiz, V., Minassian, M. L., Rivero, C. W., Sala, A., Corach, D., Alessio, A., Pozzati, M., Frider, B., et al. (2006) · Journal of Clinical Microbiology · doi:10.1128/jcm.00057-06 · Cited by 23 · see citing works
Howell, J. A., van Gemert, C. E., Lemoine, M., Thursz, M. R., & Hellard, M. E. (2014) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.12684 · Cited by 18 · see citing works
Wang, Y., Yu, L., Zhou, H., Zhou, Z., Zhu, H., Li, Y., Zheng, Z. J., Li, X., & Dong, C. (2016) · The Journal of Infection in Developing Countries · doi:10.3855/jidc.7377 · Cited by 18 · see citing works
LOCARNINI, S. A., & Shouval, D. (2014) · Journal of Virology · doi:10.1128/jvi.00234-14 · Cited by 17 · see citing works
Self-citationSu, H., Zhang, Y., Zhang, Z., Duan, L., Zhang, J., Men, K., Zhang, L., Long, Y., Xu, D., & Yan, Y. (2010) · Intervirology · doi:10.1159/000319437 · Cited by 16 · see citing works
Detection of HBsAg mutants in a population with a low prevalence of hepatitis B virus infection
Gibb, R., Nimmo, G. R., O’Loughlin, P. D., Lowe, P., & Drummond, D. (2007) · Journal of Medical Virology · doi:10.1002/jmv.20823 · Cited by 16 · see citing works
Heterogeneity analysis of the hepatitis B virus genome in intrauterine infection
Su, H., Xu, D., Li, D., Zhang, J., Lü, J., Choi, B. C. K., & Yan, Y. (2005) · Journal of Medical Virology · doi:10.1002/jmv.20454 · Cited by 16 · see citing works
The Association of Pre-S/S Gene Mutations and Hepatitis B Virus Vertical Transmission
Yin, Y., Zhang, P., Tan, Z., Zhou, J. J., Wu, L., & Hou, H. (2016) · Hepatitis Monthly · doi:10.5812/hepatmon.32160 · Cited by 15 · see citing works
Immuno-prophylaxis of babies borne to hepatitis B carrier mothers.
Tse, K., SIu, S., Yip, K., Chan, S., Que, T., Lui, W. Y. S., & Chan, P. S. (2006) · PubMed · Cited by 14 · see citing works
Pineau, P., & Tiollais, P. (2009) · Pathologie Biologie · doi:10.1016/j.patbio.2009.03.004 · Cited by 14 · see citing works
Unique surface gene variants of hepatitis B virus isolated from patients in the Philippines
Baclig, M. O., Alvarez, M., Gopez-Cervantes, J. L., & Natividad, F. F. (2013) · Journal of Medical Virology · doi:10.1002/jmv.23717 · Cited by 13 · see citing works
Article Commentary: Hepatitis B Antiviral Resistance and Vaccine Escape: Two Sides of the Same Coin
Torresi, J. (2008) · Antiviral Therapy · doi:10.1177/135965350801300314 · Cited by 13 · see citing works
Molecular evolution of hepatitis B vaccine escape variants in China, during 2000–2016
Wang, J., Qiu, J., Zhu, Y., Zhou, H., Yu, L., Ding, Y., Zhang, L., Guo, Z., & Dong, C. (2017) · Vaccine · doi:10.1016/j.vaccine.2017.09.030 · Cited by 12 · see citing works
Dambadarjaa, D., Ojima, T., Uehara, R., Watanabe, M., Oki, I., Endo, K., Takahashi, M., Okamoto, H., & Nakamura, Y. (2006) · Archives of Virology · doi:10.1007/s00705-006-0863-3 · Cited by 12 · see citing works
Mast, E. E., & Ward, J. W. (2008) · Elsevier eBooks · doi:10.1016/b978-1-4160-3611-1.50017-9 · Cited by 10 · see citing works
Tsukakoshi, T., Samuela, J., Rafai, E., Rabuatoka, U., Honda, S., Kamiya, Y., Buerano, C. C., & Morita, K. (2015) · Virology Journal · doi:10.1186/s12985-015-0267-7 · Cited by 10 · see citing works
Reinert, P., Cinquetti, S., Soubeyrand, B., Biasio, L. R., Meghlaoui, G., Thomas, S., & Watson, M. (2010) · Advances in Therapy · doi:10.1007/s12325-010-0005-x · Cited by 8 · see citing works
Hepatitis B Surface Antigen (HBsAg) Variants
Carman, W. F., Jazayeri, M., Basuni, A. A., Thomas, H. C., & Karayiannis, P. (2005) · doi:10.1002/9780470987131.ch14 · Cited by 8 · see citing works
Self-citationProgress in the Control of Hepatitis B Virus Infection among Children in Indonesia
Lusida, M. I. (2014) · Journal of Vaccines & Vaccination · doi:10.4172/2157-7560.1000247 · Cited by 7 · see citing works
No evidence of occult HBV infection in population born after mass vaccination
Aghasadeghi, M. R., Aghakhani, A., Mamishi, S., Bidari‐Zerehpoosh, F., Haghi-Ashtiani, M. T., Sabeti, S., Banifazl, M., Karami, A., Bavand, A., & Ramezani, A. (2020) · Wiener Medizinische Wochenschrift · doi:10.1007/s10354-020-00748-z · Cited by 7 · see citing works
Zhang, C., An, S., Lv, R., Li, K., Liu, H., Li, J., Tang, Y., Cai, Z., Huang, T., Long, L., et al. (2024) · Virus Research · doi:10.1016/j.virusres.2024.199317 · Cited by 6 · see citing works
Hepatitis B in Pregnancy: Specific Issues and Considerations
Ho, V., & Ho, W. L. (2012) · Journal of Antivirals & Antiretrovirals · doi:10.4172/jaa.1000046 · Cited by 5 · see citing works
Could Resistant and Escape Variants of Hepatitis B Virus Be a Problem in the future?
Özgüler, M., & Sayan, M. (2018) · Future Virology · doi:10.2217/fvl-2017-0144 · Cited by 5 · see citing works
Molecular Variants of Hepatitis B Surface Antigen (HBsAg)
Jazayeri, S. M., Alavian, S. M., Dindoost, P., Thomas, H. C., & Karayiannis, P. (2013) · doi:10.1002/9781118637272.ch8 · Cited by 5 · see citing works
Dufour, D. R. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4160-6164-9.00050-0 · Cited by 4 · see citing works
Insights from twenty years of comparative research in Pacific Large Ocean States
Shurety, A. L., Bartelet, H. A., Chawla, S., James, N. L., Lapointe, M., Zoeller, K. C., Chua, C. M., & Cumming, G. S. (2022) · Ecosystems and People · doi:10.1080/26395916.2022.2086924 · Cited by 2 · see citing works
Ghany, M. G., & Liang, T. J. (2008) · Textbook of Gastroenterology · doi:10.1002/9781444303254.ch80 · Cited by 2 · see citing works
Commentary Hepatitis B antiviral resistance and vaccine escape: two sides of the same coin
Torresi, J. (2008) · Cited by 1 · see citing works
Zehender, G., Ebranati, E., Fiaschi, L., Ciccozzi, M., & Galli, M. (2016) · Springer eBooks · doi:10.1007/978-3-319-30112-9_2 · Cited by 1 · see citing works
Evaluation of S Gene Mutations in Children with Maternally Transmitted Hepatitis B
Shahramian, I., Ostadrahimi, P., Sheikh, M., Nazari, S., Mirzaei, H., Moradi, A., Aminisefat, A., Bazı, A., Parooie, F., & Tahani, M. (2023) · Journal of Advances in Medical and Biomedical Research · doi:10.30699/jambs.31.144.57 · Cited by 1 · see citing works
Ghany, M. G., & Gara, N. (2017) · Wiley eBooks · doi:10.1002/9781119251316.ch24 · Cited by 1 · see citing works
Lok, A. S.-F., & Negro, F. (2011) · doi:10.1002/9781119950509.ch24
Induced Pluripotent Stem-cell Lines in the Clinic - Still a Long Road Ahead
Bhatt, S., & Wu, G.-X. (2015) · Journal of Human Virology & Retrovirology · doi:10.15406/jhvrv.2015.02.00044
Ghany, M. G., & Liang, T. J. (2015) · Yamada's Textbook of Gastroenterology · doi:10.1002/9781118512074.ch94
Breakthrough HBV infection in a vaccinated child due to vaccine escape mutant
Ohta, T., Ito, K., Sugiura, T., Koyama, N., Saitoh, S., Murakami, S., & Tanaka, Y. (2021) · Kanzo · doi:10.2957/kanzo.62.403
Gerlich, W. H., & Kann, M. (2010) · doi:10.1002/9780470688618.taw0261
- Authors
- Basuni, A. A., Butterworth, L., Cooksley, G., Locarnini, S., & Carman, W. F.
- Affiliations
- Gartnavel General Hospital (GB)
- Victorian Infectious Diseases Reference Laboratory (AU)
- Corresponding author
- Carman, W.F.
- ORCID
- Locarnini, S.
- Venue
- Vaccine
- Publisher
- Elsevier BV
- Published
- 2004-07
- Volume
- 22
- Issue
- 21-22
- Pages
- 2791-2799
- ISSN
- 0264-410X (ISSN-L)
- OpenAlex
- W2066212295
- Cited by
- 60
- References
- 49
- Citations by year
- 2024: 2 · 2023: 1 · 2022: 1 · 2021: 2 · 2020: 3 · 2018: 1 · 2017: 5 · 2016: 4 · 2015: 5 · 2014: 5 · 2013: 3 · 2012: 4
- FWCI
- 2.65
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Vaccine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Epidemiology › Hepatitis B Virus Studies
- Health Sciences › Medicine › Emergency Medicine › Intramuscular injections and effects
- Health Sciences › Medicine › Hepatology › Hepatitis C virus research
- Keywords
- hepatitis B virus, HBsAg mutants, vaccine escape mutants, hepatitis B vaccination, vaccine failure, Pacific Island countries, Vanuatu, Fiji, Tonga, Kiribati, vaccination coverage, cold chain
- MeSH terms
- Adult, Child, Preschool, DNA, Viral, Female, Gene Frequency, Hepatitis B, Hepatitis B Antibodies, Hepatitis B Surface Antigens, Humans, Infant, Infant, Newborn, Mutation, Pacific Islands, Risk Factors, Treatment Failure, Hepatitis B Vaccines, Immunization Programs, Reverse Transcriptase Polymerase Chain Reaction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review